Rapalogix Health Secures $20M Series A to Revolutionize Skin Health

Rapalogix Health, a biotech company from CARLSBAD, Calif., has completed a $20 million Series A funding round, accelerating the expansion of Re-Q Health™ and the development of next-generation products targeting the biological mechanisms of skin aging.